Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimizing Phototesting and Investigating Photobiology of Visible Light

NCT: NCT05964907 · ACTIVE_NOT_RECRUITING

NCT IDNCT05964907
StatusACTIVE_NOT_RECRUITING
Start Date2021-10-06
Completion2026-12-30

Brief Summary

Specific Aim 1: To determine the impact of spectral composition of the VL+UVA1 source on the associated biologic effects. Specific Aim 2: To investigate differential responses of subjects with different skin phototypes to VL+UVA1, including immediate and delayed erythema and pigmentation, and photodamage.

Frequently Asked Questions

What is Optimizing Phototesting and Investigating Photobiology of Visible Light?

Optimizing Phototesting and Investigating Photobiology of Visible Light is a clinical trial registered under NCT05964907. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05964907?

The current status of NCT05964907 (Optimizing Phototesting and Investigating Photobiology of Visible Light) is: ACTIVE_NOT_RECRUITING.

When did Optimizing Phototesting and Investigating Photobiology of Visible Light start?

Optimizing Phototesting and Investigating Photobiology of Visible Light started on 2021-10-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑